Summary
The Joint Action EU4H11 included in the EU4Health Programme and funded by the European Commission aims at strengthening capacities of EU/EEA GMP/GDP inspectorates in the global vision of mutual reliance of inspection data to better ensure quality of medicinal products and protection of Public Health. The Joint Action is steered by AGES/BASG (Austrian Agency for Health and Food Safety / Austrian Federal Office for Safety in Health Care) as Coordinator, together with the National Competent Authorities (NCAs) of France (ANSM), Croatia (HALMED) and Hungary (NCPHP) as work package leaders.
In total, 39 EU/EEA Medicines Inspectorates from a total of 29 EU/EEA countries are participating in EU4H11. They are supervising the regulatory compliance of pharmaceutical manufacturers of human and veterinary medicines throughout EU/EEA. The total budget of this Joint Action amounts to more than three Million Euros, 80 percent of the costs will be co-financed by the European Commission. The Health and Digital Executive Agency (HaDEA) as Granting Authority is managing this Joint Action EU4H11 as part of implementing the EU4Health Programme.
Project description and benefits
The project participants are the national competent authorities (NCAs) – medicines inspectorates in EU/EEA region: they are supervising the regulatory compliance (GMP - Good Manufacturing Practice) of pharmaceutical manufacturers of human and veterinary medicines throughout EU/EEA. Good manufacturing practice (GMP) refers to the guidelines for quality assurance in production processes to ensure safe and high-quality medicinal products.
The three main goals of EU4H11 are:
- Strengthening the Joint Audit Programme (JAP) for EU/EEA GMP Inspectorates: Heads of Medicines Agencies have agreed on setting up the JAP to verify the implementation and equivalence of EU/EEA GMP inspectorates with relevant provisions of European Directives into national laws, and in coherence with the Compilation of Union Procedures on Inspections. It aims to maintain mutual confidence in the EU/EEA GMP inspection systems, and consequently in the EU/EEA Inspections Network. Additionally, the JAP serves as a basis for Mutual Recognition Agreements (MRA) with Third-Countries. This Joint Action EU4H11 will work on optimising training and qualification processes for auditors as well as the JAP procedures for GMP inspections. Furthermore, the co-financing of costs related to JAP activities supports member states’ participation in the Joint Audit Programme.
- Reviewing the national implementation of the European GDP legislation / guidelines and developing a proposal to include GDP to the existing Joint Audit Programme. By promoting collaboration between EU/EEA GDP Inspectorates, the Joint Action will strengthen the EU/EEA GDP Inspectorates network and work towards a harmonization of GDP inspections standards.
- Enhancing EU/EEA GMP inspectors’ competences by establishing harmonised training and qualification processes for GMP inspectors, in cooperation with the PIC/S Inspectorates’ Academy. Furthermore, the co-financing of costs related to training activities supports member states’ participation.
EU4H11-News
Virtual JAP/JRP auditor training October 5th/6th 2023
The 2023 Virtual JAP/JRP Auditor Training was organised by ANSM (FR) on October 5th to 6th 2023 within the frame of the EU Joint Action EU4H11. It aims at strengthening capacities of EU/EEA GMP/GDP inspectorates in the global vision of mutual reliance of inspection data to better ensure quality of medicinal products and protection of Public Health. The training course was primarily targeted to auditors operating in the frameworks of the EU/EEA Joint Audit Programme (JAP) and/or the PIC/S Joint Reassessment Programme (JRP). The training was attended by more than 150 participants from 50 national competent authorities.
The training course was opened and chaired by Olivier Gross (EC/DG SANTE). Firstly, participants were introduced to basic concepts comprising goals, overview, roles, and responsibilities of the JAP/JRP programmes by Giampiero Lorenti, AIFA (IT), Chair of the Compliance Group of EMA’s GMDP Inspectors’ Working Group and Jacques Morénas, ANSM (FR), Chair of the PIC/S Sub-Committee on Training for PIC/S. The second part offered detail guidance and insights in audit planning, preparation, conduct, reporting and follow-up – as well as the specific part of observing an inspection.
The speakers, long-experienced auditors and/or persons with long experience in the field of GMP regulatory compliance programmes, shared their knowledge, best practices and facilitated discussions on the specific topics. In a third section, the 78 indicators of the audit checklist were explained in detail, to be rounded up by a presentation on audit techniques (soft skills). All along the sessions, GMP inspectors / staff of GMP inspectorates could build up knowledge and discuss with experienced auditors in various Q&A sessions to contribute regularly as an auditor in the future – and/or to strengthen the understanding of the JAP/JRP indicators as auditee. Finally, participants received detailed information about co-financing options of different JAP auditor trainings through EU4H11, directed to those EU/EEA authorities participating in EU4H11 Joint Action.
The recording of the virtual training course is available for access to EU/EEA Authorities via EU NTC and for PIC/S Participating Authorities via PIA.
EU4H11 update 11/2023: 12 months project progress
The Joint Action EU4H11 is ongoing since November 1st 2022. The Kick-off meeting for EU4H 11 was successfully organised as a hybrid meeting at AGES/BASG (AT), Vienna from December 5th to 6th 2022. During the first few months, the project plans were refined, and processes were defined. Those are continuously implemented in the four mandatory work packages. Co-financing of JAP activities and GMP inspectors’ training activities is ongoing. The activities in work packages 5 and 6 have been launched at the beginning of 2023. Work package 7 activities will start in 2024 as planned. ANSM (FR) is leading work package 5. It aims at strengthening the Joint Audit Programme (JAP) for EU/EEA GMP Inspectorates by optimising training and qualification processes for auditors as well as existing JAP processes. NCPHP (HU) is leading work package 6. It works towards harmonization of GDP inspection standards. A proposal to include GDP to the existing Joint Audit Programme will be developed.
Addition of Project Partners
The addition of seven EU/EEA Medicines Inspectorates for veterinary medicines has been completed. A total number of 39 participating partner agencies has been reached.
Recent proposals on EU-level
The Joint Audit Programme (JAP) is part of the recently published draft of the new Pharma Legislation, proposed by the European Commission to become mandatory by the respective Regulation (Article 54). According to the proposal, each Member State shall provide trained auditors. In addition, a new Procedure “EU/EEA Programme for Maintenance of Equivalence in Supervision of Good Manufacturing Practice (GMP) Compliance of Pharmaceutical Companies” has been added to the Compilation of Union Procedures on Inspections and Exchange of Information in June 2023 (Rev. 19). This new procedure details elements to achieve and maintain equivalent supervision standards throughout EU/EEA. Amongst others, the active contribution to the Joint Audit Programme by EU/EEA competent authorities through provision of auditors is expected.
Project highlights
- The qualification process for JAP auditors has been finalised.
- The first Joint Action (online) training session for JAP/JRP auditors was held from 5-6 Oct 2023. The training was organised by ANSM with additional support from the European Commission, EMA and Pharmaceutical Inspection Cooperation Scheme (PIC/S). The participation of senior auditors from European or PIC/S authorities as trainers allowed future auditors to benefit from their valuable experience. The training was attended by 150 participants. GMP inspectors / staff of GMP inspectorates have been trained in detail to contribute as an auditor in the future – and/or to strengthen the understanding of the JAP/JRP programmes / indicators as auditee. The recording of the virtual training course will be available for access to EU/EEA Authorities via EU NTC and for PIC/S Participating Authorities via PIC/S Inspectorate’s Academy (PIA).
JAP advanced training for auditors 3rd/4th October 2024
On 3rd and 4th October 2024 the French Medicines Agency ANSM organised the second training for auditors of the Joint Audit Programme (JAP) in the frame of the Joint Action: This face-to-face advanced training course was held at the ANSM facilities in Paris with the following objectives:
- To deepen the knowledge and skills acquired during the initial theoretical training, and to apply them in practical workshops; and
- To immerse the auditors in a real audit situation by carrying out a mock ANSM audit.
The training was attended by 32 participants from 18 Member States, namely Austria, Belgium, Bulgaria, Croatia, Cyprus, Germany, Estonia, Finland, France, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Slovenia, Spain, and Sweden. Furthermore, an observer from the European Commission was present. 4 experienced auditors acted as trainers: Anne Hayes (IE-HPRA), Ana Rita Martins (PT-INFARMED), Andreas Kraßnigg (AT-AGES) and Jacques Morénas (FR-ANSM).
This training course, directed at (future) auditors of the Joint Audit Programme was exceptional by simulating a joint audit of ANSM, colleagues could not only benefit from practising their (future) role applying their technical and social skills. Moreover, this course concept enabled a variety of discussions by sharing experiences of assessments and audit situations. Not only did all participants gain a deeper insight, but also elements with opportunities for improvement regarding the Joint Audit Programme itself have been revealed. This great success was built on months of intense preparatory work by a considerable team from ANSM to develop the training. In addition to detail the course concept comprising a range of colleagues involved in training delivery, the respective self-assessment and documentation of ANSM was prepared and provided.
In our role as Joint Action Coordinator and on behalf of the entire EU/EEA Inspectors Network, we herewith express our sincere gratitude to ANSM for organising this outstanding training event, as well as to the trainers for their continuous contribution to the trainings. In addition, we are pleased to welcome our colleagues to the pool of JAP auditors!
This training course, and in total three training sessions being organised by ANSM in the frame of the EU4H11 Joint Action, enable us to reach the aim of our project to maintain a substantial number of well-trained, qualified auditors to maintain the Joint Audit Programme on a long-term basis.
EU4H11 update 11/2024: 24 months of project progress
Since November 2023, the EU4H11 Joint Action Team is continuously making progress in implementing the action tasks aiming at strengthening the capacity of the GMDP inspectors’ network to enhance equivalency in inspections and GMDP regulatory compliance programmes.
Summary of achievements
Work Package 4 & 5 – Strengthening the Joint Audit Programme by co-funding of JAP activities, optimising training and qualification processes of JAP auditors and optimising existing JAP processes
- The activities of the Joint Audit Programme (JAP) are continuously co-funded: Co-funding is not only provided for travel, accommodation and subsistence costs of auditors travelling to on-site audits and face-to-face trainings. Moreover, NCAs providing auditors and sponsors to run the JAP and dedicating resources for initial and continuous training of auditors receive financial support for the respective personnel costs.
- The qualification process for new JAP auditors was applied by EMA in 2024 for assignments of 2025 audits in a pilot phase, as agreed by the Compliance Group.
- Rules on reimbursement of JAP auditors’ cost detailing provisions regarding the reimbursement of JAP auditors’ expenses, were finalised and adopted by the Compliance Group, with implementation starting JAP audits in September 2024. The major change is the application of daily allowance rates established on EC level.
- A JAP audit report review checklist was developed to harmonise the JAP audit report review amongst Compliance Group sponsors. The Compliance Group agreed in September 2024 to use the checklist for a 1-year-pilot phase.
- An advanced training course for JAP auditors was organised by ANSM at its facilities in Paris from 3rd - 4th October 2024 (refer to dedicated section).
Work Package 4 & 7 –Strengthening the capacity of EU/EEA GMP inspectors by co-funding of GMP training activities and optimising training and qualification processes of GMP inspectors
- Training activities of GMP inspectors are continuously co-funded. NCAs select trainings depending on their needs, ranging from basic to continuous training, from F2F events or online courses organised by different regulatory entities, associations and training providers to joint inspections for training purposes (Joint Inspections Training, see below).
- The Joint Action EU4H11 supported the launch of the JIT – Joint Inspection Training of EMA in 2023. The training program aims to coordinate offers and demands for observing GMP inspections for training purposes in another EU/EEA member state. Co-funding is offered both for trainers and trainees.
- In March 2024, EU/EEA GMP inspectors and EU/EEA Heads of GMP inspectorates have been invited to complete questionnaires on training and qualification of GMP inspectors, training needs and sustainability of GMP inspectorates. 35 Heads of EU/EEA GMP Inspectorates (response rate: 83%) and a total of 148 EU/EEA GMP inspectors replied to the questionnaires. The results have been shared amongst the network and are used to define and implement recommendations. Furthermore, they will be considered for further training organisation and sustainability actions.
Work Package 6 – Strengthening the EU/EEA GDP inspectors’ network by harmonising GDP inspections standards
- A questionnaire on guidelines on GDP of medicinal products for human use and wholesaling activities was drawn up to perform a review of the implementation of the EU GDP legislation and notably the GDP guidelines in national GDP legislation. The questionnaire was distributed to EU/EEA NCAs and responses of 29 member states were received. The analysis of the answers is ongoing.
- The proposal to extend the Joint Audit Programme to GDP, which was worked on since spring 2023, was finalised. It comprises a JAP GDP indicators list/audit checklist, the respective interpretation guide as well as related procedures and templates. The elaborated draft will be the basis for further discussion by the Compliance Group and finally by the entire competent EU/EEA GDP inspectorates.
Besides the work of the technical work packages, it is highlighted that the tasks of the mandatory work packages in the established frameworks (project management/coordination, dissemination, evaluation and sustainability) are continuously implemented.
Overview of EU4H11 project highlights in figures 10/2024
- A total of 20 joint audits with on-site date in the period from 01/11/2022 to 31/10/2024 have been co-financed.
- By end of October 2024, 25 NCAs out of the total 42 EU-EEA NCAs (60 %) provided auditors to maintain the Joint Audit Programme (JAP).
- 32 participants from 18 EU-EEA Member States/NCAs attended the advanced training course for JAP auditors from 3rd to 4th October 2024.
- During Joint Action runtime (1/11/2024 – 31/10/2025), we welcome additional 33 co-auditors and 14 lead auditors to run the JAP. 13 auditors-in-training join audit teams before acting as an auditor.
- By end of April 2024, a total of 74 trainings attended by 57 EU-EEA GMP inspectors have been co-financed.
- By end of October 2024, 7 joint inspections for training purposes were performed: 7 NCAs acted as hosting NCA/trainer and 4 NCAs participated as trainee in the EU/EEA cross-border JIT - Joint Inspections Training Programme.
Project details
Joint Actions in the framework of the EU4Health programme provide co-financing by the European Union in form of a direct grant to member states. National Competent Authorities must be nominated by the respective EU4Health Nominating Authority. In Austria the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) is the responsible body hereof. EU4H11 relates to the action area of implementation of pharmaceutical legislation and pharmaceutical strategy to strengthen health systems. The Federal Ministry has nominated AGES to participate in EU4H11 on behalf of Austria and provides additional financial support.
Project name: Joint Action on quality of medicines and implementation of the pharmaceutical legislation/strategy
Project acronym: EU4H11
Project management: Austrian Agency for Health an Food Safety (AGES, Medical Market Surveillance) / Austrian Federal Office for Safety in Healthcare (BASG), Mag. Andreas Kraßnigg
Project partners: 39 medicinal product inspectorates from a total of 29 EU/EEA Member States
- Austria: AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY GMBH (AGES)
- Belgium: FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS (FAMHP)
- Bulgaria: BULGARIAN DRUG AGENCY (BDA)
- Bulgaria: BULGARIAN FOOD SAFETY AGENCY (BFSA)
- Croatia: AGENCIJA ZA LIJEKOVE I MEDICINSKE PROIZVODE (HALMED)
- Cyprus: PHARMACEUTICAL SERVICES, MINISTRY OF HEALTH (PHS MOH)
- Cyprus: MINISTRY OF AGRICULTURE, RURAL DEVELOPMENT AND ENVIRONMENT OF CYPRUS (MoA-Vet Services)
- Czechia: STATNI USTAV PRO KONTROLU LECIV (SÚKL)
- Czechia: USTAV PRO STATNI KONTROLU VETERINARNICH BIOPREPARATU A LECIV (USKVBL)
- Denmark: LAEGEMIDDELSTYRELSEN (DKMA)
- Estonia: RAVIMIAMET
- Finland: LAAKEALAN TURVALLISUUS-JA KEHITTAMISKESKUS (FIMEA)
- France: AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE (ANSM)
- France: AGENCE NATIONALE DE LA SECURITE SANITAIRE DE L'ALIMENTATION, DE L'ENVIRONNEMENT ET DU TRAVAIL (ANSES)
- Germany: NATIONAL CENTRE FOR HEALTH PROTECTION OF MEDICINAL PRODUCTS AND MEDICAL DEVICES (ZLG)
- Greece: ETHNIKOS ORGANISMOS FARMAKON (EOF)
- Hungary: ORSZAGOS GYOGYSZERESZETI ES ELELMEZES-EGESZSEGUGYI INTEZET (OGYÉI/NIPN)
- Hungary: NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL (NÉBIH)
- Iceland: ICELANDIC MEDICINES AGENCY (LYFJASTOFNUN)
- Ireland: HEALTH PRODUCTS REGULATORY AUTHORITY (HPRA)
- Italy: AGENZIA ITALIANA DEL FARMACO (AIFA)
- Italy: MINISTERO DELLA SALUTE (MoH-DGSAF-IT)
- Latvia: ZALU VALSTS AGENTURA (ZVA)
- Latvia: PARTIKAS UN VETERINARAIS DIENESTS (FVS)
- Lithuania: VALSTYBINE VAISTU KONTROLES TARNYBAPRIE LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJOS (VVKT)
- Lithuania: VALSTYBINĖ MAISTO IR VETERINARIJOS TARNYBA / State Food and Veterinary Service (VMVT)
- Luxembourg: MINISTERE DE LA SANTE (MOHLUX)
- Malta: THE MEDICINES AUTHORITY (MALTA MA)
- Malta: MINISTRY FOR AGRICULTURE, FISHERIES AND ANIMAL RIGHTS Animal Health and Welfare Department (MAFA-AHWD)
- Netherlands: MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT (IGJ-NL)
- Norway: THE NORWEGIAN MEDICINES AGENCY (NOMA)
- Poland: GLOWNY INSPEKTORAT FARMACEUTYCZNY (CPI)
- Portugal: INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP (INFARMED)
- Portugal: DIRECCAO-GERAL DE ALIMENTACAO E VETERINARIA (DGAV)
- Romania: AGENTIA NATIONALA A MEDICAMENTULUI SI A DISPOZITIVELOR MEDICALE DIN ROMANIA - NATIONAL AGENCY FOR MEDICINES AND MEDICAL DEVICES OF ROMANIA (ANMDMR)
- Slovakia: STATNY USTAV PRE KONTROLU LIECIV (SÚKL SK)
- Slovenia: JAVNA AGENCIJA REPUBLIKE SLOVENIJE ZA ZDRAVILA IN MEDICINSKE PRIPOMOCKE (JAZMP)
- Spain: AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (AEMPS)
- Sweden: LAKEMEDELSVERKET (MPA)
Funding: The Joint Action EU4H11 is co-financed by the European Union. Grant Agreement 101082515- EU4H-2021-JA2-IBA
Project duration: 01.11.2022 until 31.12.2025
Further information
EU4H11 Project coordination: AGES / BASG eu4h11@ages.at
Joint Audit Programme Website HMA
Last updated: 22.11.2024
automatically translated